Clinical Trials in Georgia

Showing 8421-8440 of 19,050 trials

Intravenous Ganaxolone as Adjunctive Therapy to Treat Subjects With Status Epilepticus

NCT03350035

This study will evaluate the effectiveness and safety of an investigational drug, IV ganaxolone, as adjunctive therapy to standard of care to treat subjects with status epilepticus.

Status EpilepticusConvulsive Status EPILEPTICUSNon Convulsive Status Epilepticus+1 more

Marinus Pharmaceuticals17 participantsStarted Feb 2018

Wilmington, Delaware, United States • Miami, Florida, United States • Atlanta, Georgia, United States +5 more locations

COMPLETEDNA65 miles

Cryovagotomy Diabetes Trial

NCT04276051

The pilot study will assess the feasibility and efficacy of cryoablation procedure to freeze the vagus nerve in obese patients with type 2 diabetes. Aim 1 will focus on changes in glycemic control. Aim 2 will evaluate differences in body weight and anthropometric measurements. This study will provide much needed data for a novel therapeutic intervention to manage obese patients with type 2 diabetes.

Diabetes Type 2Diabetes MellitusObesity

Emory University5 participantsStarted Oct 2020

Atlanta, Georgia, United States • Atlanta, Georgia, United States • Atlanta, Georgia, United States +2 more locations

Intravenous Ganaxolone as Adjunctive Therapy to Treat Subjects With Status Epilepticus

Cryovagotomy Diabetes Trial

Find Trials by Condition in Georgia

A Safety Study of SGN-LIV1A in Breast Cancer Patients

Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects With Heart Failure

An Investigational Immuno-therapy Safety and Effectiveness Study of Nivolumab in Combination With Brentuximab Vedotin to Treat Non-Hodgkin Lymphomas

A Study of Maribavir Compared to Valganciclovir to Treat Cytomegalovirus Infections in People Who Have Received Stem Cell Transplants

Allo vs Hypomethylating/Best Supportive Care in MDS (BMTCTN1102)

Effects of Oral Levosimendan on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis (ALS): Open-Label Extension

Study to Evaluate the Efficacy of Tenapanor as Adjunctive Therapy to Phosphate Binder Therapy

Phase 1/1b Study of MGCD516 in Patients With Advanced Cancer

Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb Spasticity

A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)

A Study Evaluating the Safety and Efficacy of Upadacitinib in Adults With Active Ankylosing Spondylitis

A Safety and Efficacy Study of FCR001 vs Standard of Care in de Novo Living Donor Kidney Transplantation

A Phase 1 Study of Intravesical VAX014 for Instillation in Subjects With Non-Muscle Invasive Bladder Cancer

The Use of Penicillin Allergy Clinical Decision Rule to Enable Direct Oral Penicillin Challenge

Study of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs)

Phase 2, Open-Label, Single Arm Study, With BST-236 in Adults With R/R AML or Higher-Risk MDS

Bacteriophage Therapy in Patients With Urinary Tract Infections

Gene Therapy for Male Patients With Danon Disease (DD) Using RP-A501; AAV9.LAMP2B